Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Accounts Payables (2024 - 2026)

Carlsmed filings provide 2 years of Accounts Payables readings, the most recent being $4.5 million for Q4 2025.

  • On a quarterly basis, Accounts Payables rose 85.78% to $4.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.5 million, a 85.78% increase, with the full-year FY2025 number at $4.5 million, up 85.78% from a year prior.
  • Accounts Payables hit $4.5 million in Q4 2025 for Carlsmed, up from $2.7 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $4.5 million in Q4 2025 to a low of $2.4 million in Q4 2024.